Filing Details
- Accession Number:
- 0001232524-15-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-15 19:43:44
- Reporting Period:
- 2015-01-13
- Filing Date:
- 2015-01-15
- Accepted Time:
- 2015-01-15 19:43:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1544589 | Sawochka Suzanne Hooper | C/O Jazz Pharmaceuticals Plc Connaught House, 1 Burlington Rd, Fl. 4 Dublin 4 L2 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2014-12-05 | 220 | $0.00 | 47,575 | No | 5 | G | Direct | |
Ordinary Shares | Acquisiton | 2015-01-13 | 1,851 | $46.83 | 49,426 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2015-01-13 | 1,851 | $161.73 | 47,575 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Nonstatutory Stock Option (right to buy) | Disposition | 2015-01-13 | 1,851 | $0.00 | 1,851 | $46.83 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
52,407 | 2022-08-08 | No | 4 | M | Direct |
Footnotes
- The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- As of the date of this report, the remaining ordinary shares subject to this option are vested with respect to 28,790 shares and will vest with respect to 14,085 shares in equal monthly installments from February 9, 2015 to December 9, 2015 and with respect to 9,532 shares in equal monthly installments from January 9, 2016 to August 9, 2016.